Tatva Chintan Pharma Chem Limited (TATVA) Share Price
NSE · Basic Materials · Specialty Chemicals · ISIN INE0GK401011
Key metrics
- Market Cap
- ₹3,805 Cr
- P/E Ratio
- 73.91
- EPS
- 22.01
- Book Value
- 334.2
- P/B Ratio
- 4.89
- ROE
- 5.38%
- ROCE
- 6.24%
- Debt / Equity
- 0.15
- Net Margin
- 8.31%
- Revenue Growth
- 32.18%
- Profit Growth
- 636.11%
- Dividend Yield
- 0.12%
- 52W High
- ₹1,838.10
- 52W Low
- ₹976.40
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
- Headquarters
- Vadodara, India
- Promoter Holding
- 74.16%
The full Tatva Chintan Pharma Chem Limited analysis
Create a free account to open the complete TATVA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.